Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma, the most common primary brain tumor in adults, according to results of a new trial.

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

A bill filed in the Texas House of Representatives this week threatens to charge transgender Texans with a crime for ...

With one of the largest tuberculosis (TB) outbreaks in US history, Kansas has more to worry about than its recent Super Bowl ...

Scientists have identified a rare genetic mutation in ITSN1 that increases the risk of Parkinson’s disease by up to tenfold, ...

TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

A new accelerated theta-burst stimulation protocol may be a viable alternative to more intensive and costly neuromodulation ...

Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have developed a drug shown to significantly extend survival time for patients with glioblastoma, ...

An outbreak of tuberculosis, or TB—a lung disease that is often accompanied by a hacking cough—began in January 2024 in ...